Cited by 39Treatment of Major DepressionTryptophan and brain disordersNeuroscience and Neuropharmacology Research

Subanesthetic ketamine reverses neuronal and astroglial metabolic activity deficits in a social defeat model of depression

Open access
Mishra, Pravin K., Kumar, Arvind, Behar, Kevin L., Patel, Anant B.·2018·Journal of Neurochemistry

Abstract

Depression is one of the most debilitating neuropsychiatric disorders. Most of the current antidepressants have long remission time and low recovery rate. This study explores the impact of ketamine on neuronal and astroglial metabolic activity in prefrontal cortex in a social defeat (SD) model of depression. C57BL/6 mice were subjected to a social defeat paradigm for 5 min a day for 10 consecutive days. Ketamine (10 mg/kg, intraperitoneal) was administered to mice for two consecutive days following the last defeat stress. Mice were infused with [1,6‐13 C 2]glucose or [2‐13 C]acetate to assess neuronal and astroglial metabolic activity, respectively, together with proton‐observed carbon‐edited nuclear magnetic resonance spectroscopy in prefrontal cortex tissue extract. The 13 C labeling of amino acids from glucose and acetate was decreased in SD mice. Ketamine treatment in SD mice restored sucrose preference, social interaction and immobility time to control values. Acute subanesthetic ketamine restored the 13 C labeling of brain amino acids from glucose as well as acetate in SD mice to the respective control values, suggesting that rates of neuronal and astroglial tricarboxylic acid (TCA) cycle and neurotransmitter cycling were re‐established to normal levels. The finding of improved energy metabolism in SD mice suggests that fast anti‐depressant action of ketamine is linked with improved neurotransmitter cycling. image

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/jnc.14544

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. Patel A. B., de Graaf R. A., Mason G. F., Rothman D. L., Shulman R. G. and Behar K. L. (2005) The contribution of GABA to glutamate/ glutamine cycling and energy metabolism in the rat cortex in vivo. Proc. Natl Acad. Sci. USA 102, 5588-5593.
  2. Videbech P. (2000) PET measurements of brain glucose metabolism and blood flow in major depressive disorder: a critical review. Acta Psychiatr. Scand. 101, 11-20.

Cited by

Sorted by citations

Authors
Mishra, P. K., Kumar, A., Behar, K. L., & Patel, A. B.
Affiliations
  • Centre for Cellular and Molecular Biology (IN)
  • Yale University (US)
Corresponding author
Patel, Anant B.
Venue
Journal of Neurochemistry
Publisher
Wiley
Published
2018-08-16
Volume
146
Issue
6
Pages
722-734
ISSN
  • 0022-3042 (ISSN-L)
  • 1471-4159
OpenAlex
W2811032630
Cited by
39
References
11
Citations by year
2026: 7 · 2025: 4 · 2024: 4 · 2023: 4 · 2022: 5 · 2021: 7 · 2020: 5 · 2019: 3
FWCI
2.42
Type
journal article
Language
en
Open access
Locations
  • Journal of Neurochemistry (publishedVersion)
  • PubMed (publishedVersion)
Funders
Department of Biotechnology (BT/PR4014/MED/30/673/2011, BT/PR4019/MED/30/675/2011)
Topics
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords
ketamine, subanesthetic ketamine, depression, social defeat, prefrontal cortex, neuronal metabolism, TCA cycle, brain energy metabolism, amino acid labeling, antidepressant mechanism, sucrose preference, immobility time
MeSH terms
Acetates, Analgesics, Animals, Astrocytes, Carbon Isotopes, Depressive Disorder, Disease Models, Animal, Food Preferences, Glucose, Hierarchy, Social, Interpersonal Relations, Ketamine, Male, Mice, Inbred C57BL, Neurons, Magnetic Resonance Spectroscopy, Stress, Psychological, Sucrose, Sweetening Agents, Swimming, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review